Safety and Anti-Disease Activity of Oral Tosedostat (CHR-2797) in Elderly Subjects With Refractory or Relapsed AML
Completed · Phase 2
Conditions studied: Acute Myeloid Leukemia, AML
In brief
The purpose of this study is to evaluate the efficacy and safety of tosedostat in elderly patients suffering from refractory or relapsed AML.
Key facts
- Study ID
- NCT00780598
- Run by
- Chroma Therapeutics
- People needed
- 76
- Starts
- 2009-10-01
- Expected to finish
- 2011-03-01
- Last updated by the study team
- 2012-06-28
Who can join
Age: 60 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- UCLA School of Medicine — Los Angeles, California, United States
- Washington Cancer Institute — Washington D.C., District of Columbia, United States
- M.D. Anderson Cancer Center Orlando — Orlando, Florida, United States
- Emory University Clinic — Atlanta, Georgia, United States
- University of Chicago Medical Center — Chicago, Illinois, United States
- University of Michigan Health System — Ann Arbor, Michigan, United States
- Washington University, Oncology/Bone Marrow Transplant — St Louis, Missouri, United States
- John Theurer Cancer Center, Hackensack University Medical Center, — Hackensack, New Jersey, United States
- Monter Cancer Center — Lake Success, New York, United States
- Memorial Sloan-Kettering Cancer Center — New York, New York, United States
- Weill Cornell Medical College - New York Presbyterian Hospital — New York, New York, United States
- Stony Brook University Medical Center — Stony Brook, New York, United States
- Montefiore Medical Center Weiler Division — The Bronx, New York, United States
- Duke Univeristy Medical Center — Durham, North Carolina, United States
- Taussig Cancer Institute — Cleveland, Ohio, United States
- MD Anderson Cancer Center — Houston, Texas, United States
- Froedtert Hospital — Milwaukee, Wisconsin, United States
- Princess Margaret Hopsital — Toronto, Ontario, Canada
- Royal Victoria Hospital — Montreal, Quebec, Canada
- VUMC — Amsterdam, Netherlands
- Erasmus MC — Rotterdam, Netherlands
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.